Decentralized Clinical Trials (DCT)

Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there more than one type of consent? Find out here.

The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the future of eConsent here.

Castor announced continued support for the WHO Solidarity trial, the world’s largest adaptive COVID-19 trial.

Learn why myTomorrows utilizes Castor to monitor treatment and assess benefit/risk its users, connecting patients with expanded trial access.

Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing…

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…